Table 2. Sexually transmitted infection and past 30-day inconsistent condom use with any partner across baseline, 14-week and 9-month post-partum follow-upa.
| 14 weeks postpartum | 9 months postpartum | |||||
| n | % | p-value | n | % | p-value | |
| Sexually transmitted infectionb | ||||||
| HIV-positive | ||||||
| Treatment | 214 | 22.9 | 0.32 | – | – | – |
| Control | 203 | 27.1 | – | – | ||
| HIV-negative | ||||||
| Treatment | 349 | 16.6 | 0.58 | – | – | – |
| Control | 358 | 15.1 | – | – | ||
| Inconsistent condom usec | ||||||
| HIV-positive | ||||||
| Treatment | 209 | 11.5 | 0.06 | 197 | 15.2 | 0.65 |
| Control | 208 | 6.3 | 198 | 13.6 | ||
| HIV-negative | ||||||
| Treatment | 353 | 17.6 | 0.36 | 357 | 28.1 | 0.009 |
| Control | 360 | 20.3 | 337 | 37.4 | ||
a
Unimputed sample sizes and proportions for each group. P-values are based on chi-square tests of differences in proportions between intervention and control group. Sample size differs across groups, outcomes, and assessment periods due to attrition and missing data.
b
Baseline STIs were treated so that incident STIs at 14 week follow-up could be evaluated. No STI testing was conducted at 9-month post-partum.
c
Women who were not sexually active were coded as “0” for inconsistent condom use.